Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients

  title={Waldenstr{\"o}m's macroglobulinemia: clinical course and prognostic factors in 60 patients},
  author={M.-C. Kyrtsonis and T. Vassilakopoulos and M. Angelopoulou and M. Siakantaris and F. Kontopidou and M. Dimopoulou and V. Boussiotis and D. Gribabis and K. Konstantopoulos and G. Vaiopoulos and P. Fessas and C. Kittas and G. Pangalis},
  journal={Annals of Hematology},
  • M.-C. Kyrtsonis, T. Vassilakopoulos, +10 authors G. Pangalis
  • Published 2001
  • Medicine
  • Annals of Hematology
  • Abstract. Waldenström's macroglobulinemia (WM) is a lymphoplasmacytic lymphoma characterized by the presence in patients' serum of an IgM monoclonal component. We report on our experience with 60 WM patients, focusing on their clinical findings, response to treatment, and the possible identification of prognostic factors. Of these patients, 70% presented with fatigue, and lymphadenopathy was observed in 22%, splenomegaly in 18%, hepatomegaly in 13%, and extranodal site of involvement in 6… CONTINUE READING
    52 Citations
    Prognostic factors in symptomatic Waldenstrom's macroglobulinemia.
    • 78
    Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
    • 46
    Waldenström's Macroglobulinemia: A Review of Therapy
    • 8
    Waldenström's macroglobulinemia.
    • 10
    • PDF


    Waldenström's macroglobulinaemia.
    • 25
    Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.
    • 151
    Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity.
    • 108